Mifepristone Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200 mg, 300 mg

Reference Brands: Mifeprex (USA), Mifegyne (EU)

Category: Women's Health

Mifepristone is an oral medication used for medical termination of early pregnancy and for the management of hypercortisolism in specific medical conditions. It works by blocking progesterone, a hormone essential for pregnancy continuation. Mifepristone is typically used together with misoprostol for medical abortion protocols. In some regions, it is also approved for treatment of Cushing’s syndrome due to its glucocorticoid receptor blockade. Mifepristone is available in Tablets and strengths such as 200 mg, 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Mifepristone is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Mifepristone can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Mifepristone is an oral medication primarily used for medical termination of early pregnancy and as part of reproductive health management. It belongs to the class of progesterone receptor antagonists, which work by blocking the action of progesterone, a hormone essential for maintaining pregnancy. By inhibiting progesterone, Mifepristone causes changes in the uterine lining and detachment of the embryo, making it an effective option for non-surgical pregnancy termination under medical supervision.

The medication is usually administered in tablet form and is often followed by a second drug, such as Misoprostol, to induce uterine contractions and complete the termination process. Mifepristone is recommended for use in early pregnancy and must be taken under strict guidance of a healthcare professional to ensure safety and effectiveness. Its use requires careful patient assessment, including confirmation of gestational age and evaluation of any underlying health conditions.

Healthcare providers monitor patients for possible side effects, including bleeding, cramping, nausea, or gastrointestinal discomfort. Proper medical follow-up is essential to confirm the completion of the process and to address any complications promptly.

Overall, Mifepristone is a reliable and clinically established option for early medical termination of pregnancy. When used appropriately under professional supervision, it provides an effective, non-surgical alternative while maintaining safety and patient care standards in reproductive health management.